Ruiz de Azúa, I <br/><br/>
Reduced phospholipase C-beta activity and isoform expression in the cerebellum of TS65Dn mouse: a model of Down syndrome.  [electronic resource] 

 -  Journal of neuroscience research  Nov 2001 
 - 540-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0360-4012 
<br/><br/><label>Standard No.: </label>10.1002/jnr.10019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Calcium--metabolism<br/>Cell Membrane--drug effects<br/>Cerebellum--drug effects<br/>Cerebral Cortex--enzymology<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Down Syndrome--enzymology<br/>Down-Regulation--drug effects<br/>GTP-Binding Proteins--drug effects<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Guanosine 5'-O-(3-Thiotriphosphate)--pharmacokinetics<br/>Isoenzymes--deficiency<br/>Male<br/>Mice<br/>Mice, Neurologic Mutants<br/>Muscarinic Agonists--pharmacology<br/>Muscarinic Antagonists--pharmacology<br/>Phosphatidylinositol 4,5-Diphosphate--genetics<br/>Phospholipase C beta<br/>Protein Isoforms--deficiency<br/>Receptor, Serotonin, 5-HT2A<br/>Receptors, Muscarinic--drug effects<br/>Receptors, Serotonin--drug effects<br/>Serotonin Antagonists--pharmacology<br/>Serotonin Receptor Agonists--pharmacology<br/>Signal Transduction--drug effects<br/>Subcellular Fractions--drug effects<br/>Tritium--pharmacokinetics<br/>Type C Phospholipases--deficiency